New injection HRS-7249 tested for high cholesterol in first human study
NCT ID NCT06541457
First seen Oct 31, 2025 · Last updated May 13, 2026 · Updated 25 times
Summary
This early-stage study tested a single injection of HRS-7249 in 32 to 48 healthy adults with mildly to moderately high cholesterol. The main goal was to check safety and how the drug moves through the body. Participants received either the drug or a placebo, and researchers monitored for side effects and drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310009, China
Conditions
Explore the condition pages connected to this study.